z-logo
Premium
Placental transfer and maternal midazolam kinetics
Author(s) -
Kanto J,
Sjövall S,
Erkkola R,
Himberg JJ,
Kangas L
Publication year - 1983
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.1983.107
Subject(s) - midazolam , medicine , anesthesia , morning , diazepam , sedation , benzodiazepine , evening , sedative , clinical pharmacology , pharmacology , physics , receptor , astronomy
Midazolam was given in a single 15‐mg oral dose as a sedative the evening before elective cesarean section. Twelve hours later, levels of this new benzodiazepine were measureable in the fetomaternal entity in only one of 13 cases. After 15 mg midazolam orally or 0.05 mg/kg midazolam intramuscularly 15 to 60 min before elective cesarean section, there was evident transfer of drug into the placenta, but transfer took place more slowly than with diazepam. On the basis of kinetics derived from maternal serum concentrations after oral, intramuscular, or intravenous dosing, midazolam appears to have a rapid onset and short duration of action, which was also evident from subjective assessments by the patients. There was wide interindividual variation in the gastrointestinal absorption of midazolam in full‐term pregnant women. Clinically, midazolam nevertheless seemed to be very useful for nocturnal sedation before elective cesarean section; it ensures a mean duration of sleep of about 6 hr and there are virtually no detectable levels of drug in the fetomaternal entity the next morning. Clinical Pharmacology and Therapeutics (1983) 33 , 786–791; doi: 10.1038/clpt.1983.107

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here